News
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) dropped 5.3% during trading on Thursday . The company traded as low as $1.23 and last traded at $1.25. Approximately 18,546 shares changed ...
Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging few years.
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza ...
11dOpinion
Zacks Investment Research on MSN5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...
23andMe, a biotech company offering genetic testing through ... prominent biotech firms have played a pivotal role in advancing high-profile cold cases, aiding in the capture of criminals by ...
17d
Investing News Network on MSNTop 5 Small-cap Biotech Stocks of 2025The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations and increased deals involving biotech ...
The company did not disclose how many employees ... 75% of them are heading for the exits. The most high-profile departure will be the biotech’s chief medical officer Maria Koehler, M.D ...
China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines as previously ...
Me recently filed for bankruptcy. Here's how users can download and delete their data from the platform ahead of the sale.
Phil King’s investment firm was the largest shareholder in Opthea, the eye treatment play that could become insolvent after a poor medical result.
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...
A new year means a new Fierce Biotech Fundraising Tracker to ... Of course, we'll still profile innovative new companies and larger rounds in-depth, while we focus more coverage on clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results